Artwork for EADV Podcast
Science

EADV Podcast

EADV

The official podcast of the European Academy of Dermatology and Venereology. Newest research in dermatology and venereology, interviews with notable doctors, professors and researchers: a focused look on today’s dermatology and venereology and new developments moving towards the future.

  • 170 episodes
  • Updated July 21

Episodes170

  • Jan 18, 2022 · 9 min

    E50: Editor’s Picks January 2022

    Join us as we go through the JEADV Editor's Picks of January 2022: (1) Dermatologic origin of a fatal C. ciferrii systemic infection (2) Emollient use in hot environments among neonates for eczema prevention: how much is enough? (3) Non-invasive visualization of human skin (4) Acute self-limiting erythema multiforme after SARS-CoV-2 vaccination Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17818

  • Jan 11, 2022 · 26 min

    E49: Insights into Paediatrics Dermatology from the first-ever JEACP Editor-in-Chief

    This week JEADV Clinical Practice Editor-in-Chief Dr. Antonio Torrelo talks about his three decades of experience in Paediatrics Dermatology, highlighting the most important skills and challenges of treating children with skin diseases. Moreover, Dr. Torrelo shares some key facts about JEACP and reveals how a day in the life of the Editor of EADV's new Open Access journal looks like. Visit https://bit.ly/EADV_JEACP to learn more about JEADV Clinical Practice

  • Jan 4, 2022 · 15 min

    E48: Cosmetic Dermatology: Challenging Situations Part 2

    This week Prof. Ashraf Badawi covers more topics connected with challenging situations in cosmetic dermatology. In this second episode of a two-part- series he discusses laser and light-based therapies and injectables in autoimmune diseases, particularly Lupus and considers how to, and when not to, treat patients with psychological disorders seeking aesthetic procedures. He brings practical clinical experience as well as the current research to the discussion. Not an EADV Member? Click Here for more information on the advantages and opportunities that only EADV Members have- including access to webcasts such as this one.

  • Dec 21, 2021 · 9 min

    E47: Editor’s Picks December 2021

    Join us as we go through the JEADV Editor's Picks of December 2021: (1) Skin conditions affect politicians too (2) Evaluating a chemical peel, non-invasively (3) SARS-CoV-2 transmission via sweat: searching for evidence (4) Undertreatment of scabies Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17763

  • Dec 14, 2021 · 26 min

    E46: The Role Of Autoantibodies In Itchy And Blistering Diseases

    Could better understanding of the role of autoantibodies hold the key to personalised treatments in itchy and blistering diseases? This week we bring together experts Prof. Kridin and Dr. Meijer to discuss their recent JEADV publications concerning the role of autoantibodies in itchy and blistering diseases. Prof. Kridin talks about the pathophysiology and therapeutic approaches to treat patients with bullous pemphigoid and comorbid psoriasis, followed by Dr. Meijer’s explanation regarding the role of IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients. References https://onlinelibrary.wiley.com/doi/10.1111/jdv.17013 https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16996 Not an EADV Member? Click Here for more information on the advantages and opportunites that only EADV Members have.

  • Dec 7, 2021 · 14 min

    E45: Cosmetic Dermatology: Challenging Situations Part 1

    Should you stop an anticoagulant for thrombosis to prevent bruising after cosmetic procedures? What changed during the pandemic? Can ablative laser plumes harm operating room personnel? This week Prof. Ashraf Badawi discusses challenging situations that can arise in cosmetic dermatology. He brings practical clinical experience as well as the current research to the discussion. Not an EADV Member? Click Here for more information on the advantages and opportunities that only EADV Members have- including access to webcasts such as this one.

  • Nov 23, 2021 · 10 min

    E44: Editor’s Picks November 2021

    Join us as we go through the JEADV Editor's Picks of November 2021: (1) Long-term safety data for a monoclonal antibody used in psoriasis (2) Preventing anaphylactoid symptoms following Covid-19 vaccination (3) Innovative surgery option for bromhidrosis (4) Surprising trends in syphilis Read the editor's picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17691

  • Nov 16, 2021 · 33 min

    E43: The Evolving Field of Dermato-oncology: A License to Examine

    This week EADV Advocacy Working Group Leader Myrto Trakatelli talks with Stella Siskou about topics including EPIDERM, the EADV Advocacy Working Group, and a position paper on the role of dermatologists in the evolving field of Dermato-oncology. The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16849

  • Nov 2, 2021 · 30 min

    E42: Changing Treatment Landscape in Psoriasis

    This week Dr. Mark Lebwohl from Icahn School of Medicine at Mount Sinai joins us to discuss the latest treatment options for psoriasis and his research focusing on new topical therapies for the management of the disease. Links to the six articles discussed can be found here: Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results from a double-blind phase 3b trial (CLARITY) Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 study Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion inmoderate-to-severe plaque psoriasis: phase 3 open-label study Itch: an under-recognized problem in psoriasis

  • Oct 19, 2021 · 9 min

    E41: Editor‘s Picks October 2021

    Join us as we go through the JEADV Editor's Picks of October 2021: (1) Are skin types equally represented in Scandinavian dermatology textbooks? (2) Apremilast for palmoplantar pustulosis under study (3) The link between autoimmune bullous diseases and neurological diseases (4) Investigating the cancer risk of using a biologic drug in atopic dermatitis Read the editor's picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17616

  • Oct 12, 2021 · 27 min

    E40: Pemphigus Vulgaris and Foliaceus: Latest management advancements

    This week esteemed Professor Branka Marinović shares her experience as Secretary General of the EADV (2017-2021) and reflects on some significant ways how the Academy has changed in the past years. Join us as Prof. Marinovic talks about how the “Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus” facilitated the everyday work of Dermatologists and improved quality of care. Finally, the importance of collaboration between the Autoimmune Blistering Diseases Task Force of the EADV and patient organizations is also highlighted. The guidelines can be read here: Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the EADV

  • Oct 5, 2021 · 20 min

    E39: Life on the Ocean Wave: Success of a targeted skin cancer screening programme

    This month we discuss a recent publication reporting on the success of a targeted skin cancer screening initiative at a sailing festival with author Professor Khosrotehrani, a clinician-scientist and dermatologist at the University of Queensland, and the Diamantina Institute, Brisbane. Listen as moderator Dr Sarah Walsh explores the challenges and implications of delivering such a screening programme in the unique location of Hamilton Island, off the coast of Queensland. Read all about this interesting subject here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17062 💡Did you know that a subscription to the high-impact factor JEADV is included in the EADV Membership?

  • Sep 21, 2021 · 9 min

    E38: Editor’s Picks September 2021

    Join us as we go through the JEADV Editor's Picks of September 2021: (1) Promising debut for a new botulinum toxin (2) Does atopic dermatitis impact future education levels? (3) Beyond histamine: itch in scabies (4) Mental health and treatment response of anogenital warts: a prospective study Read the editor's picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17528

  • Sep 14, 2021 · 18 min

    E37: Meet EADV President, Prof. Alexander Stratigos

    In the run-up to the 30th Congress of the European Academy of Dermatology and Venereology, Prof Alexander Stratigos, talks about the accomplishments of the Academy in his first year as President and the challenges and opportunities brought about by the COVID-19 pandemic that have paved the way to a digital transformation and a strengthened voice in Europe.

  • Sep 7, 2021 · 25 min

    E36:Vulva Dermatology Part II: Lichen planus and lichen sclerosus

    Lichen Planus and Lichen sclerosus are two conditions that affect the vulva. Due to popular request, this week we will revisit the a webcast where Dr Fiona Lewis brings practical clinical experience focusing on diagnosis and basic management of these conditions.

  • Aug 24, 2021 · 10 min

    E35: Editor's Picks August 2021

    Join us as we go through the JEADV Editor's Picks of August 2021: (1) Genetic advances in treating epidermolysis bullosa (2) Searching for a tolerable topical treatment of primary axillary hyperhidrosis (3) RASopathies and the importance of skin examinations (4) Molecular testing of tinea Read the Editor's Picks here

  • Aug 17, 2021 · 28 min

    E34: Lesion-directed Screening: A Way to Make Skin Cancer Screening Cost-effective

    Early detection of skin cancer is still a major challenge in dermatology practice today. While surveillance programs are offered to high-risk patients, systematic total-body examination in the general population is not cost-effective. Lesion-directed screening may be a way to optimise skin cancer detection in the general population and use available time as efficient as possible in daily dermatology practice. Prof. Jan Gutermuth explores this topic with Prof. Lieve Brochez. The research discussed in this webcast can be found in the JEADV here: "Lesion-directed screening to optimize skin cancer detection in dermatology practice: an observational study"

  • Aug 10, 2021 · 25 min

    E33: Photoprotection: The Big Picture

    We have a vast amount of research about the impact of UVB, UVA, visible light and infrared radiation on skin and subsequent dermatoses. We also have extensive information and research on how to mitigate risk from sun exposure. Yet, how do we communicate this to a public that doesn't often look much beyond the SPF number on a bottle of sunblock? Dr Elena Rossi explores this topic with Prof. Thierry Passeron to delve deeper into the proper habits that dermatologists, and really everyone, should know. The JEADV article is available here Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel

  • Jul 27, 2021 · 10 min

    E32: Editor's Picks July 2021

    Join us as we go through the JEADV Editor's Picks of July 2021: (1) Novel presentation of pigtail hairs (2) Seeing the light: moving past sun protection factor and ultraviolet B when choosing sunscreen (3) Antifungal resistance may be spreading in Europe (4) Agreeing on the correct histopathologic diagnosis of melanoma Read the Editor's picks here: https://www.onlinelibrary.wiley.com/doi/10.1111/jdv.17389

  • Jul 20, 2021 · 24 min

    E31: Digitalization and Dermatology: an ever-closer and inseparable combination

    In a digital world, are you ready to adjust, evolve and stay ahead of the curve when it comes to offering a state-of-the-art experience to your patients and improving their quality of life? Digitalization has made tremendous progress during the COVID pandemic; it is here to stay and its impact is already visible on (tele)dermatology. Join today’s discussion between Prof. Jan Gutermuth (University of Brussels) and Mr. Maicher (Global Partner & Director of Allianz Global Strategic Partnerships) to get an insight on the recent healthcare system shifts, learn more about digital platforms and related virtual services, not to mention the importance of building strategic partnerships.